Group 1 - The core focus of Aipeng Medical (300753) in recent days has been on the progress of its brain-computer interface business and institutional research interest [1] - The anesthesia puncture robot project is still in the design and development stage, with no significant breakthroughs reported [1] - Brain-computer interface technology has become a key focus for institutional research, highlighting advancements in EEG technology and the commercialization of cutting-edge brain state research, driven by policy support and technological breakthroughs [1] Group 2 - The stock price of Aipeng Medical has shown volatility, influenced by sentiment in the brain-computer interface sector [2] - On February 11, 2026, the stock price fell by 1.11% with a trading volume of 118 million yuan and a net outflow of main funds [2] - The stock had previously risen by 4.13% on February 6, 2026, closing at 34.57 yuan, driven by inflows related to the brain-computer interface concept [2] - As of February 12, 2026, the stock price was 33.39 yuan, reflecting a 1.37% increase from the previous day, but a cumulative decline of 3.41% over the past five days, indicating short-term market divergence [2]